137 related articles for article (PubMed ID: 11920588)
1. Transcriptional inactivation of TP73 expression in oligodendroglial tumors.
Dong S; Pang JC; Hu J; Zhou LF; Ng HK
Int J Cancer; 2002 Mar; 98(3):370-5. PubMed ID: 11920588
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.
Corn PG; Kuerbitz SJ; van Noesel MM; Esteller M; Compitello N; Baylin SB; Herman JG
Cancer Res; 1999 Jul; 59(14):3352-6. PubMed ID: 10416592
[TBL] [Abstract][Full Text] [Related]
3. Concurrent sequence variation of TP53 and TP73 genes in anaplastic astrocytoma.
Anselmo NP; Rey JA; Almeida LO; Custódio AC; Almeida JR; Clara CA; Santos MJ; Casartelli C
Genet Mol Res; 2009 Oct; 8(4):1257-63. PubMed ID: 19876867
[TBL] [Abstract][Full Text] [Related]
4. EMP3 overexpression is associated with oligodendroglial tumors retaining chromosome arms 1p and 19q.
Li KK; Pang JC; Chung NY; Ng YL; Chan NH; Zhou L; Poon WS; Ng HK
Int J Cancer; 2007 Feb; 120(4):947-50. PubMed ID: 17187361
[TBL] [Abstract][Full Text] [Related]
5. Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss.
Riemenschneider MJ; Reifenberger J; Reifenberger G
Int J Cancer; 2008 Jun; 122(11):2503-10. PubMed ID: 18302158
[TBL] [Abstract][Full Text] [Related]
6. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
7. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.
Möllemann M; Wolter M; Felsberg J; Collins VP; Reifenberger G
Int J Cancer; 2005 Jan; 113(3):379-85. PubMed ID: 15455350
[TBL] [Abstract][Full Text] [Related]
8. Absence of mutation of the p73 gene in astrocytic neoplasms.
Alonso ME; Bello MJ; Lomas J; Gonzalez-Gomez P; Arjona D; De Campos JM; Gutierrez M; Isla A; Vaquero J; Rey JA
Int J Oncol; 2001 Sep; 19(3):609-12. PubMed ID: 11494043
[TBL] [Abstract][Full Text] [Related]
9. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
Hong C; Maunakea A; Jun P; Bollen AW; Hodgson JG; Goldenberg DD; Weiss WA; Costello JF
Cancer Res; 2005 May; 65(9):3617-23. PubMed ID: 15867356
[TBL] [Abstract][Full Text] [Related]
10. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.
Wolter M; Reifenberger J; Blaschke B; Ichimura K; Schmidt EE; Collins VP; Reifenberger G
J Neuropathol Exp Neurol; 2001 Dec; 60(12):1170-80. PubMed ID: 11764089
[TBL] [Abstract][Full Text] [Related]
11. Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors.
Dong SM; Pang JC; Poon WS; Hu J; To KF; Chang AR; Ng HK
J Neuropathol Exp Neurol; 2001 Aug; 60(8):808-16. PubMed ID: 11487055
[TBL] [Abstract][Full Text] [Related]
12. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.
Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J
BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334
[TBL] [Abstract][Full Text] [Related]
13. Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas.
Martinez-Delgado B; Melendez B; Cuadros M; Jose Garcia M; Nomdedeu J; Rivas C; Fernandez-Piqueras J; Benítez J
Int J Cancer; 2002 Nov; 102(1):15-9. PubMed ID: 12353228
[TBL] [Abstract][Full Text] [Related]
14. Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors.
Kuo LT; Kuo KT; Lee MJ; Wei CC; Scaravilli F; Tsai JC; Tseng HM; Kuo MF; Tu YK
Int J Cancer; 2009 Jun; 124(12):2872-9. PubMed ID: 19330828
[TBL] [Abstract][Full Text] [Related]
15. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in oligodendroglial tumors.
Kuo LT; Lu HY; Lee CC; Tsai JC; Lai HS; Tseng HM; Kuo MF; Tu YK
Cancer Med; 2016 Aug; 5(8):1830-9. PubMed ID: 27367901
[TBL] [Abstract][Full Text] [Related]
16. Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status.
Domínguez G; Silva J; Silva JM; García JM; Larrondo FJ; Vargas J; Sanfrutos L; Provencio M; España P; Bonilla F
Genes Chromosomes Cancer; 2001 Jun; 31(2):99-106. PubMed ID: 11319797
[TBL] [Abstract][Full Text] [Related]
17. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
[TBL] [Abstract][Full Text] [Related]
18. TP73 allelic expression in human brain and allele frequencies in Alzheimer's disease.
Li Q; Athan ES; Wei M; Yuan E; Rice SL; Vonsattel JP; Mayeux RP; Tycko B
BMC Med Genet; 2004 Jun; 5():14. PubMed ID: 15175114
[TBL] [Abstract][Full Text] [Related]
19. The p73 gene is not mutated in oligodendrogliomas which frequently have a deleted region at chromosome 1p36.3.
Tsujimoto T; Mochizuchi S; Iwadate Y; Namba H; Nagai M; Kawamoto T; Sunahara M; Yamaura A; Nakagawara A; Sakiyama S; Tagawa M
Anticancer Res; 2000; 20(4):2495-7. PubMed ID: 10953317
[TBL] [Abstract][Full Text] [Related]
20. Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia.
Hatzimichael E; Benetatos L; Dasoula A; Dranitsaris G; Tsiara S; Georgiou I; Syrrou M; Stebbing J; Coley HM; Crook T; Bourantas KL
Leuk Res; 2009 Sep; 33(9):1272-5. PubMed ID: 19423161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
